Successful treatment of hemorrhagic syndrome due to an acquired, combined deficiency of factors VII and X in a patient with multiple myeloma and amyloidosis.
Elezović
I
I
Djukanović
R
R
Rolović
Z
Z
D000686:Amyloidosis / Q000150:complications*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D005168:Factor VII Deficiency / Q000150:complications*; D005171:Factor X Deficiency / Q000150:complications*; D006801:Humans; D007020:Hypoprothrombinemias / Q000150:complications*; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D011241:Prednisone / Q000008:administration & dosage; D012771:Shock, Hemorrhagic / Q000209:etiology / Q000628:therapy*; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D003520:Cyclophosphamide; D008558:Melphalan; D011241:Prednisone